ALB and pancreatic ductal adenocarcinoma: The NCCN (National Comprehensive Cancer Network) recommends that patients with advanced pancreatic ductal adenocarcinoma should receive a combination of folic acid and albumin paclitaxel + gemcitabine for 4–6 months, followed by radiotherapy (39).